Evidence map›Paper›PMID 42358823›Full record

ArticleOncology research2026

Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic Target.

Jian-Lei Kang, Yu-Jie Xu, Qi-Tai Zhao, Bing Zhang, Xin Xu, Bo Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jian-Lei KangDepartment of Neurosurgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yu-Jie XuDepartment of Oncology, Henan Provincial People's Hospital, Zhengzhou, China.
Qi-Tai ZhaoBiotherapy Center and Cancer Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Bing ZhangDepartment of Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Xin XuDepartment of Neurosurgery, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Bo YangDepartment of Neurosurgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorBrain NeoplasmsGliomaInsulin-Like Growth Factor Binding Protein 2AnimalsCell Line, TumorGene Expression Regulation, NeoplasticHumansMiceNeoplasm Recurrence, LocalPrognosisSingle-Cell AnalysisBiomarkers, TumorIGFBP2 protein, humanInsulin-Like Growth Factor Binding Protein 2Gliomaheterogeneityimmunosuppressive tumor microenvironmentinsulin-like growth factor binding protein 2

Identifiers

PMID42358823
PMCPMC13291989

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.